tiprankstipranks
Cardiff Oncology, Inc. (DE:XE7C)
FRANKFURT:XE7C
Germany Market

Cardiff Oncology (XE7C) Cash flow

Compare
2 Followers

Cardiff Oncology Cash Flow

DE:XE7C's free cash flow for Q3 2024 was $-10.46M. For the 2024 fiscal year, DE:XE7C's free cash flow was decreased by $3.24M and operating cash flow was $-10.46M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -30.89M$ -33.82M$ -23.04M$ -16.31M$ -13.27M
Investing Cash Flow
$ 36.20M$ 38.15M$ -131.45M$ -211.88K$ -68.00K
Financing Cash Flow
$ 0.00$ 75.00K$ 35.45M$ 137.31M$ 12.08M
End Cash Position
$ 21.66M$ 16.35M$ 11.94M$ 130.98M$ 10.20M
Free Cash Flow
$ -31.47M$ -34.71M$ -23.25M$ -16.53M$ -13.34M
Currency in USD

Cardiff Oncology Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis